A medicine currently being tested as a chemoprevention agent for multiple types of cancer has more than one trick in its bag when it comes to preventing stomach cancer, Vanderbilt researchers have discovered.
Original Article: Cancer prevention drug also reduces virulence of H. pylori bacterium